STÆRDAL KIRURGI ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2018
2018/9
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  3.8% 3.3% 2.9% 3.0% 4.6%  
Credit score (0-100)  53 56 58 56 45  
Credit rating  BBB BBB BBB BBB BBB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2018
2018/9
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9

Net sales  0 0 0 0 0  
Gross profit  2,555 2,628 2,592 2,544 5,628  
EBITDA  310 426 429 377 3,441  
EBIT  -18.2 136 190 138 3,301  
Pre-tax profit (PTP)  -75.0 68.6 124.9 130.1 3,120.7  
Net earnings  -60.9 51.2 94.5 103.5 2,456.6  
Pre-tax profit without non-rec. items  -75.0 68.6 125 130 3,121  

 
See the entire income statement

Balance sheet (kDKK) 
2018
2018/9
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9

Tangible assets total  162 111 50.7 50.7 0.0  
Shareholders equity total  871 922 1,016 1,120 3,577  
Interest-bearing liabilities  2,506 2,075 2,141 451 220  
Balance sheet total (assets)  4,475 4,568 4,286 2,573 5,066  

Net Debt  2,506 1,593 1,830 451 -4,846  
 
See the entire balance sheet

Volume 
2018
2018/9
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  2,555 2,628 2,592 2,544 5,628  
Gross profit growth  18.0% 2.9% -1.4% -1.9% 121.2%  
Employees  2 2 2 2 2  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  4,475 4,568 4,286 2,573 5,066  
Balance sheet change%  1.4% 2.1% -6.2% -40.0% 96.9%  
Added value  -18.2 136.4 189.5 137.6 3,301.4  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -657 -580 -539 -479 -2,225  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  -3.0 1.0 2.0 3.0 4.0  

Profitability 
2018
2018/9
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  -0.7% 5.2% 7.3% 5.4% 58.7%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.6% 3.8% 5.2% 5.3% 88.3%  
ROI %  0.7% 4.6% 6.4% 6.4% 115.9%  
ROE %  -5.3% 5.7% 9.8% 9.7% 104.6%  

Solidity 
2018
2018/9
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
Equity ratio %  19.5% 20.2% 23.7% 43.5% 70.6%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  807.3% 373.8% 426.7% 119.8% -140.8%  
Gearing %  287.8% 225.1% 210.7% 40.3% 6.1%  
Net interest  0 0 0 0 0  
Financing costs %  4.8% 4.6% 5.0% 3.9% 75.1%  

Liquidity 
2018
2018/9
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
Quick Ratio  0.5 0.6 0.7 0.4 3.4  
Current Ratio  0.5 0.6 0.7 0.4 3.4  
Cash and cash equivalent  0.0 482.2 311.4 0.0 5,065.5  

Capital use efficiency 
2018
2018/9
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  -1,500.6 -1,197.2 -865.5 -571.1 304.9  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2018
2018/9
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
Net sales / employee  0 0 0 0 0  
Added value / employee  -9 68 95 69 1,651  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  155 213 214 189 1,721  
EBIT / employee  -9 68 95 69 1,651  
Net earnings / employee  -30 26 47 52 1,228